A. Tayoun, A. Tunkey, C. Pugh, T. Ross, T. Shah et al., A Comprehensive Assay for CFTR Mutational Analysis Using Next-Generation Sequencing, Clinical Chemistry, vol.59, issue.10, pp.1481-1489, 2013.
DOI : 10.1373/clinchem.2013.206466

A. Aissat, A. De-becdelievre, L. Golmard, C. Vasseur, C. Costa et al., Combined computational-experimental analyses of CFTR exon strength uncover predictability of exon skipping level, Hum Mutat, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00797975

N. Amrani, S. Dong, F. He, R. Ganesan, S. Ghosh et al., Aberrant termination triggers nonsense-mediated mRNA decay, Biochemical Society Transactions, vol.34, issue.1, pp.39-42, 2006.
DOI : 10.1042/BST0340039

D. Andersen, CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE, American Journal of Diseases of Children, vol.56, issue.2, pp.344-99, 1938.
DOI : 10.1001/archpedi.1938.01980140114013

M. Anderson and M. Welsh, Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains, Science, vol.257, issue.5077, pp.1701-1705, 1992.
DOI : 10.1126/science.1382316

L. Bidou, V. Allamand, J. Rousset, and O. Namy, Sense from nonsense: therapies for premature stop codon diseases, Trends in Molecular Medicine, vol.18, issue.11, pp.679-88, 2012.
DOI : 10.1016/j.molmed.2012.09.008

M. Boyle, Nonclassic cystic fibrosis and CFTR-related diseases, Current Opinion in Pulmonary Medicine, vol.9, issue.6, pp.498-503, 2003.
DOI : 10.1097/00063198-200311000-00009

A. Cantin, J. Hanrahan, G. Bilodeau, L. Ellis, A. Dupuis et al., Cystic Fibrosis Transmembrane Conductance Regulator Function Is Suppressed in Cigarette Smokers, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.10, pp.1139-1183, 2006.
DOI : 10.1164/rccm.200508-1330OC

C. Castellani, H. Cuppens, M. Macek, J. Cassiman, J. Kerem et al., Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice, Journal of Cystic Fibrosis, vol.7, issue.3, pp.179-96, 2008.
DOI : 10.1016/j.jcf.2008.03.009

J. Choi, D. Muallem, K. Kiselyov, M. Lee, P. Thomas et al., Aberrant CFTR-dependent HCO3-transport in mutations associated with cystic fibrosis, Nature, vol.410, issue.6824, pp.94-101, 2001.
DOI : 10.1038/35065099

C. Chu, B. Trapnell, S. Curristin, G. Cutting, and R. Crystal, Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA, Nature Genetics, vol.98, issue.2, pp.151-157, 1993.
DOI : 10.1038/ng0293-151

J. Clain, J. Fritsch, J. Lehmann-che, M. Bali, N. Arous et al., Two Mild Cystic Fibrosis-associated Mutations Result in Severe Cystic Fibrosis When Combined in Cis and Reveal a Residue Important for Cystic Fibrosis Transmembrane Conductance Regulator Processing and Function, Journal of Biological Chemistry, vol.276, issue.12, pp.9045-9054, 2001.
DOI : 10.1074/jbc.M008979200

J. Clain, J. Lehmann-che, I. Dugueperoux, N. Arous, E. Girodon et al., protein leads to mild cystic fibrosis phenotype, Human Mutation, vol.98, issue.9157, pp.360-71, 2005.
DOI : 10.1002/humu.20156

J. Clain, J. Lehmann-che, E. Girodon, J. Lipecka, A. Edelman et al., A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype, Human Genetics, vol.473, issue.6, pp.454-60, 2005.
DOI : 10.1007/s00439-004-1246-z

M. Claustres, J. Altieri, C. Guittard, C. Templin, F. Chevalier-porst et al., Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations ?, BMC Medical Genetics, vol.4, issue.1, p.19, 2004.
DOI : 10.1089/109065700316516

L. Clunes, C. Davies, R. Coakley, A. Aleksandrov, A. Henderson et al., Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration, The FASEB Journal, vol.26, issue.2, pp.533-578, 2012.
DOI : 10.1096/fj.11-192377

L. Cui, L. Aleksandrov, X. Chang, Y. Hou, L. He et al., Domain Interdependence in the Biosynthetic Assembly of CFTR, Journal of Molecular Biology, vol.365, issue.4, pp.981-94, 2007.
DOI : 10.1016/j.jmb.2006.10.086

W. Dalemans, P. Barbry, G. Champigny, S. Jallat, K. Dott et al., Altered chloride ion channel kinetics associated with the ??F508 cystic fibrosis mutation, Nature, vol.354, issue.6354, pp.526-534, 1991.
DOI : 10.1038/354526a0

D. Boeck, K. Wilschanski, M. Castellani, C. Taylor, C. Cuppens et al., Cystic fibrosis: terminology and diagnostic algorithms, Thorax, vol.61, issue.7, pp.627-662, 2006.
DOI : 10.1136/thx.2005.043539

A. Divac, A. Nikolic, M. Mitic-milikic, L. Nagorni-obradovic, N. Petrovic-stanojevic et al., High frequency of the R75Q CFTR variation in patients with chronic obstructive pulmonary disease, Journal of Cystic Fibrosis, vol.3, issue.3, pp.189-91, 2004.
DOI : 10.1016/j.jcf.2004.05.049

R. Dorfman, T. Nalpathamkalam, C. Taylor, T. Gonska, K. Keenan et al., tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?, Clinical Genetics, vol.6, issue.5, pp.464-73, 2010.
DOI : 10.1111/j.1399-0004.2009.01351.x

L. Du, R. Damoiseaux, S. Nahas, K. Gao, H. Hu et al., Nonaminoglycoside compounds induce readthrough of nonsense mutations, The Journal of Experimental Medicine, vol.59, issue.10, pp.2285-97, 2009.
DOI : 10.1038/sj.clpt.6100012

I. Dugueperoux, G. Bellis, J. Lesure, M. Renouil, H. Flodrops et al., Cystic fibrosis at the Reunion Island (France): spectrum of mutations and genotype-phenotype for the Y122X mutation, Journal of Cystic Fibrosis, vol.3, issue.3, pp.185-193, 2004.
DOI : 10.1016/j.jcf.2004.03.011

A. Eberle, L. Stalder, H. Mathys, R. Orozco, and O. Muhlemann, Posttranscriptional Gene Regulation by Spatial Rearrangement of the 3??? Untranslated Region, PLoS Biology, vol.78, issue.4, p.92, 2008.
DOI : 10.1371/journal.pbio.0060092.sg005

P. Eckford, C. Li, M. Ramjeesingh, and C. Bear, Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner, Journal of Biological Chemistry, vol.287, issue.44, pp.36639-36688, 2012.
DOI : 10.1074/jbc.M112.393637

P. Farrell, B. Rosenstein, T. White, F. Accurso, C. Castellani et al., Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report, The Journal of Pediatrics, vol.153, issue.2, pp.4-14, 2008.
DOI : 10.1016/j.jpeds.2008.05.005

C. Ferec and G. Cutting, Assessing the Disease-Liability of Mutations in CFTR. Cold Spring Harb Perspect Med, 2012.

C. Floquet, I. Hatin, J. Rousset, and L. Bidou, Statistical Analysis of Readthrough Levels for Nonsense Mutations in Mammalian Cells Reveals a Major Determinant of Response to Gentamicin, PLoS Genetics, vol.86, issue.3, p.1002608, 2012.
DOI : 10.1371/journal.pgen.1002608.s012
URL : https://hal.archives-ouvertes.fr/hal-00686519

S. Gonzalez, T. Beghyn, J. Jia, N. Debreuck, G. Berte et al., Rescue of nonsense mutations by amlexanox in human cells, Orphanet Journal of Rare Diseases, vol.7, issue.1, p.58, 2012.
DOI : 10.1186/1745-6215-10-30
URL : https://hal.archives-ouvertes.fr/inserm-00783891

M. Graille and B. Seraphin, Surveillance pathways rescuing eukaryotic ribosomes lost in translation, Nature Reviews Molecular Cell Biology, vol.31, issue.11, pp.727-762, 2012.
DOI : 10.1038/nrm3457
URL : https://hal.archives-ouvertes.fr/hal-00814136

D. Grove, M. Rosser, H. Ren, A. Naren, and D. Cyr, Mechanisms for Rescue of Correctable Folding Defects in CFTR??F508, Molecular Biology of the Cell, vol.20, issue.18, pp.4059-69, 2009.
DOI : 10.1091/mbc.E08-09-0929

M. Haardt, M. Benharouga, D. Lechardeur, N. Kartner, and G. Lukacs, C-terminal Truncations Destabilize the Cystic Fibrosis Transmembrane Conductance Regulator without Impairing Its Biogenesis: A NOVEL CLASS OF MUTATION, Journal of Biological Chemistry, vol.274, issue.31, pp.21873-21880, 1999.
DOI : 10.1074/jbc.274.31.21873

L. He, L. Aleksandrov, L. Cui, T. Jensen, K. Nesbitt et al., Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR

A. Hinzpeter, A. Aissat, A. De-becdelievre, E. Bieth, E. Sondo et al., Alternative Splicing of In-Frame Exon Associated with Premature Termination Codons: Implications for Readthrough Therapies, Human Mutation, vol.8, issue.10, pp.287-91, 2013.
DOI : 10.1002/humu.22236

A. Hinzpeter, A. Aissat, E. Sondo, C. Costa, N. Arous et al., Alternative Splicing at a NAGNAG Acceptor Site as a Novel Phenotype Modifier, PLoS Genetics, vol.499, issue.10, 2010.
DOI : 10.1371/journal.pgen.1001153.s001
URL : https://hal.archives-ouvertes.fr/inserm-00542805

T. Jensen, M. Loo, S. Pind, D. Williams, A. Goldberg et al., Multiple proteolytic systems, including the proteasome, contribute to CFTR processing, Cell, vol.83, issue.1, pp.129-164, 1995.
DOI : 10.1016/0092-8674(95)90241-4

R. Kellermayer, Translational readthrough induction of??pathogenic nonsense mutations, European Journal of Medical Genetics, vol.49, issue.6, pp.445-50, 2006.
DOI : 10.1016/j.ejmg.2006.04.003

B. Kerem, J. Rommens, J. Buchanan, D. Markiewicz, T. Cox et al., Identification of the cystic fibrosis gene: genetic analysis, Science, vol.245, issue.4922, pp.1073-80, 1989.
DOI : 10.1126/science.2570460

H. Lee and J. Dougherty, Pharmaceutical therapies to recode nonsense mutations in inherited diseases, Pharmacology & Therapeutics, vol.136, issue.2, pp.227-66, 2012.
DOI : 10.1016/j.pharmthera.2012.07.007

L. Linde, S. Boelz, M. Nissim-rafinia, Y. Oren, M. Wilschanski et al., Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin, Journal of Clinical Investigation, vol.117, issue.3, pp.683-92, 2007.
DOI : 10.1172/JCI28523DS1

G. Lucotte, S. Hazout, D. Braekeleer, and M. , Complete map of cystic fibrosis mutation DF508 frequencies in Western Europe and correlation between mutation frequencies and incidence of disease, Hum Biol, vol.67, pp.797-803, 1995.

L. Maquat, When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells, RNA, vol.1, pp.453-65, 1995.

L. Maquat, Nonsense-Mediated mRNA Decay: Splicing, Translation And mRNP Dynamics, Nature Reviews Molecular Cell Biology, vol.5, issue.2, pp.89-99, 2004.
DOI : 10.1038/nrm1310

J. Mendoza, A. Schmidt, Q. Li, E. Nuvaga, T. Barrett et al., Requirements for Efficient Correction of ??F508 CFTR Revealed by Analyses of Evolved Sequences, Cell, vol.148, issue.1-2, pp.164-74, 2012.
DOI : 10.1016/j.cell.2011.11.023

O. Muhlemann, Recognition of nonsense mRNA: towards a unified model: Figure 1, Biochemical Society Transactions, vol.36, issue.3, pp.497-501, 2008.
DOI : 10.1042/BST0360497

F. Pagani and F. Baralle, Opinion: Genomic variants in exons and introns: identifying the splicing spoilers, Nature Reviews Genetics, vol.74, issue.5, pp.389-96, 2004.
DOI : 10.1093/hmg/9.2.259

N. Pedemonte, G. Lukacs, K. Du, E. Caci, O. Zegarra-moran et al., Small-molecule correctors of defective ??F508-CFTR cellular processing identified by high-throughput screening, Journal of Clinical Investigation, vol.115, issue.9, pp.2564-71, 2005.
DOI : 10.1172/JCI24898DS1

N. Pedemonte, V. Tomati, E. Sondo, E. Caci, E. Millo et al., Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations, Journal of Biological Chemistry, vol.286, issue.17, pp.15215-15241, 2011.
DOI : 10.1074/jbc.M110.184267

I. Protasevich, Z. Yang, C. Wang, S. Atwell, X. Zhao et al., Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1, Protein Science, vol.401, issue.10, pp.1917-1948, 2010.
DOI : 10.1002/pro.479

W. Rabeh, F. Bossard, H. Xu, T. Okiyoneda, M. Bagdany et al., Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ??F508 CFTR Folding and Function, Cell, vol.148, issue.1-2, pp.150-63, 2012.
DOI : 10.1016/j.cell.2011.11.024

S. Raju, P. Jackson, C. Courville, C. Mcnicholas, P. Sloane et al., Cigarette Smoke Induces Systemic Defects in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function, Am J Respir Crit Care Med, 2013.

B. Ramsey, J. Davies, N. Mcelvaney, E. Tullis, S. Bell et al., Mutation, New England Journal of Medicine, vol.365, issue.18, pp.1663-72, 2011.
DOI : 10.1056/NEJMoa1105185

C. Raynal, D. Baux, C. Theze, C. Bareil, M. Taulan et al., Gene, Human Mutation, vol.61, issue.7, pp.774-84, 2013.
DOI : 10.1002/humu.22291

M. Reddy and P. Quinton, Selective activation of cystic fibrosis transmembrane conductance regulator Cl-and HCO3-conductances, JOP, vol.2, pp.212-220, 2001.

H. Ren, D. Grove, D. L. Rosa, O. Houck, S. Sopha et al., VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1, Molecular Biology of the Cell, vol.24, issue.19, pp.3016-3040, 2013.
DOI : 10.1091/mbc.E13-05-0240

B. Rosenstein, Nonclassic cystic fibrosis: A clinical conundrum, Pediatric Pulmonology, vol.137, issue.1, pp.10-12, 2003.
DOI : 10.1002/ppul.10286

S. Rowe, P. Sloane, L. Tang, K. Backer, M. Mazur et al., Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54, Journal of Molecular Medicine, vol.96, issue.11, pp.1149-61, 2011.
DOI : 10.1007/s00109-011-0787-6

A. Schneider, J. Larusch, X. Sun, A. Aloe, J. Lamb et al., Combined Bicarbonate Conductance-Impairing Variants in CFTR and SPINK1 Variants Are Associated With Chronic Pancreatitis in Patients Without Cystic Fibrosis, Gastroenterology, vol.140, issue.1, pp.162-71, 2011.
DOI : 10.1053/j.gastro.2010.10.045

F. Seibert, P. Linsdell, T. Loo, J. Hanrahan, J. Riordan et al., Cytoplasmic Loop Three of Cystic Fibrosis Transmembrane Conductance Regulator Contributes to Regulation of Chloride Channel Activity, Journal of Biological Chemistry, vol.271, issue.44, pp.27493-27502, 1996.
DOI : 10.1074/jbc.271.44.27493

I. Sermet-gaudelus, M. Renouil, A. Fajac, L. Bidou, B. Parbaille et al., In vitroprediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study, BMC Medicine, vol.171, issue.Suppl 2, p.5, 2007.
DOI : 10.1164/rccm.200406-740OC

D. Sheppard, D. Rich, L. Ostedgaard, R. Gregory, A. Smith et al., Mutations in CFTR associated with mild-disease-form CI- channels with altered pore properties, Nature, vol.362, issue.6416, pp.160-164, 1993.
DOI : 10.1038/362160a0

T. Shoshani, A. Augarten, E. Gazit, N. Bashan, Y. Yahav et al., Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease, Am J Hum Genet, vol.50, pp.222-230, 1992.

A. Silva, P. Ribeiro, A. Inacio, S. Liebhaber, and L. Romao, Proximity of the poly(A)-binding protein to a premature termination codon inhibits mammalian nonsense-mediated mRNA decay, RNA, vol.14, issue.3, pp.563-76, 2008.
DOI : 10.1261/rna.815108

P. Sosnay, C. Castellani, M. Corey, R. Dorfman, J. Zielenski et al., Evaluation of the Disease Liability of CFTR Variants, Methods Mol Biol, vol.742, pp.355-72, 2011.
DOI : 10.1007/978-1-61779-120-8_21

C. Thauvin-robinet, A. Munck, F. Huet, E. Genin, G. Bellis et al., The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening, Journal of Medical Genetics, vol.46, issue.11, pp.752-760, 2009.
DOI : 10.1136/jmg.2009.067215

F. Van-goor, S. Hadida, P. Grootenhuis, B. Burton, D. Cao et al., Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770, Proceedings of the National Academy of Sciences, vol.106, issue.44, pp.18825-18855, 2009.
DOI : 10.1073/pnas.0904709106

F. Van-goor, S. Hadida, P. Grootenhuis, B. Burton, J. Stack et al., Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809, Proceedings of the National Academy of Sciences, vol.108, issue.46, pp.18843-18851, 2011.
DOI : 10.1073/pnas.1105787108

F. Van-goor, K. Straley, D. Cao, J. Gonzalez, S. Hadida et al., Rescue of ??F508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules, AJP: Lung Cellular and Molecular Physiology, vol.290, issue.6, pp.1117-1147, 2006.
DOI : 10.1152/ajplung.00169.2005

F. Van-goor, H. Yu, B. Burton, C. Huang, and B. Hoffman, Ivacaftor potentiates multiple mutant CFTR forms, Pediatr Pulmonol, vol.47, p.31, 2012.

C. Ward, S. Omura, and R. Kopito, Degradation of CFTR by the ubiquitin-proteasome pathway, Cell, vol.83, issue.1, pp.121-128, 1995.
DOI : 10.1016/0092-8674(95)90240-6

E. Welch, E. Barton, J. Zhuo, Y. Tomizawa, W. Friesen et al., PTC124 targets genetic disorders caused by nonsense mutations, Nature, vol.250, issue.7140, pp.87-91, 2007.
DOI : 10.1038/nature05756

M. Welsh, B. Ramsey, F. Accurso, and G. Cutting, Cystic fibrosis, 2001.

M. Welsh and A. Smith, Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis, Cell, vol.73, issue.7, pp.1251-1255, 1993.
DOI : 10.1016/0092-8674(93)90353-R

K. Will, T. Dork, M. Stuhrmann, V. Der-hardt, H. Ellemunter et al., Transcript analysis of CFTR nonsense mutations in lymphocytes and nasal epithelial cells from cystic fibrosis patients, Human Mutation, vol.10, issue.3, pp.210-230, 1995.
DOI : 10.1002/humu.1380050305

M. Wilschanski, Y. Yahav, Y. Yaacov, H. Blau, L. Bentur et al., Stop Mutations, New England Journal of Medicine, vol.349, issue.15, pp.1433-1474, 2003.
DOI : 10.1056/NEJMoa022170

O. Woodward, D. Tukaye, J. Cui, P. Greenwell, L. Constantoulakis et al., Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules, Proceedings of the National Academy of Sciences, vol.110, issue.13, pp.5223-5231, 2013.
DOI : 10.1073/pnas.1214530110

L. Ye, J. Knapp, P. Sangwung, J. Fettinger, A. Verkman et al., Pyrazolylthiazole as ??F508-Cystic Fibrosis Transmembrane Conductance Regulator Correctors with Improved Hydrophilicity Compared to Bithiazoles, Journal of Medicinal Chemistry, vol.53, issue.9, pp.3772-81, 2010.
DOI : 10.1021/jm100235h